Australia’s CSL builds out its transplant franchise with acquisition of Canadian biotech Vitaeris June 9, 2020 By Tamra Sami No Comments PERTH, Australia – CSL Ltd. said its subsidiary, CSL Behring, has agreed to exercise an option to acquire Canadian biotech Vitaeris Inc. for its lead phase III asset for rejection in solid organ kidney transplant patients.Read More